Kezar Life Sciences IncNASDAQ:KZRNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6000
- TODAY'S CHANGE (%)-0.0343 (-5.4075%)
- Bid / Lots0.6100/ 44
- Ask / Lots0.6560/ 20
- Open / Previous Close0.6400 / 0.6343
- Day Range
- 52 Week Range
- Volume9,811,566
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KZR |
|---|---|---|
| 09:32 ET | 3011 | 0.64 |
| 09:38 ET | 1200 | 0.6346 |
| 09:39 ET | 520 | 0.6301 |
| 09:41 ET | 501 | 0.6301 |
| 09:48 ET | 15293 | 0.6305 |
| 09:52 ET | 200 | 0.6324 |
| 09:54 ET | 300 | 0.6343 |
| 09:56 ET | 400 | 0.6343 |
| 09:57 ET | 300 | 0.6343 |
| 09:59 ET | 355 | 0.6324 |
| 10:01 ET | 9700 | 0.6328 |
| 10:03 ET | 5550 | 0.634299 |
| 10:06 ET | 1700 | 0.6444 |
| 10:08 ET | 1400 | 0.64205 |
| 10:10 ET | 100 | 0.64 |
| 10:12 ET | 3500 | 0.6339 |
| 10:14 ET | 400 | 0.6339 |
| 10:17 ET | 13213 | 0.6384 |
| 10:19 ET | 600 | 0.64 |
| 10:21 ET | 500 | 0.64 |
| 10:24 ET | 15600 | 0.64035 |
| 10:26 ET | 800 | 0.6403 |
| 10:28 ET | 1100 | 0.6381 |
| 10:30 ET | 800 | 0.6381 |
| 10:32 ET | 1600 | 0.6381 |
| 10:33 ET | 1800 | 0.6399 |
| 10:35 ET | 1600 | 0.6381 |
| 10:37 ET | 500 | 0.6381 |
| 10:39 ET | 700 | 0.6401 |
| 10:42 ET | 500 | 0.6401 |
| 10:44 ET | 900 | 0.6381 |
| 10:46 ET | 300 | 0.64005 |
| 10:48 ET | 670 | 0.64 |
| 10:50 ET | 1504 | 0.6383 |
| 10:51 ET | 200 | 0.6401 |
| 10:53 ET | 600 | 0.6383 |
| 10:55 ET | 200 | 0.64015 |
| 11:00 ET | 800 | 0.6401 |
| 11:02 ET | 523 | 0.6383 |
| 11:04 ET | 2830 | 0.6382 |
| 11:06 ET | 700 | 0.6407 |
| 11:08 ET | 753 | 0.6382 |
| 11:09 ET | 13799 | 0.634 |
| 11:11 ET | 400 | 0.63715 |
| 11:13 ET | 400 | 0.634 |
| 11:15 ET | 700 | 0.634 |
| 11:18 ET | 700 | 0.634 |
| 11:20 ET | 1400 | 0.63715 |
| 11:22 ET | 1000 | 0.6342 |
| 11:24 ET | 1200 | 0.6342 |
| 11:26 ET | 800 | 0.6372 |
| 11:27 ET | 415 | 0.6372 |
| 11:29 ET | 867 | 0.6373 |
| 11:31 ET | 1128 | 0.6346 |
| 11:33 ET | 1200 | 0.6374 |
| 11:36 ET | 757 | 0.6374 |
| 11:38 ET | 1000 | 0.6346 |
| 11:40 ET | 570 | 0.6374 |
| 11:42 ET | 305 | 0.6346 |
| 11:44 ET | 432 | 0.6401 |
| 11:45 ET | 200 | 0.6346 |
| 11:47 ET | 700 | 0.6347 |
| 11:49 ET | 26481 | 0.63 |
| 11:51 ET | 26989 | 0.6293 |
| 11:54 ET | 1700 | 0.623 |
| 11:56 ET | 31921 | 0.6233 |
| 11:58 ET | 1400 | 0.6233 |
| 12:00 ET | 17933 | 0.62495 |
| 12:02 ET | 28771 | 0.62745 |
| 12:03 ET | 2100 | 0.6274 |
| 12:05 ET | 14537 | 0.62 |
| 12:07 ET | 3300 | 0.62 |
| 12:09 ET | 1930 | 0.6223 |
| 12:12 ET | 4891 | 0.6226 |
| 12:14 ET | 1696 | 0.6252 |
| 12:16 ET | 1140 | 0.6211 |
| 12:18 ET | 15606 | 0.6147 |
| 12:20 ET | 8820 | 0.6116 |
| 12:21 ET | 3987 | 0.6137 |
| 12:23 ET | 3609 | 0.6234 |
| 12:25 ET | 668 | 0.6223 |
| 12:27 ET | 2970 | 0.62235 |
| 12:30 ET | 2386 | 0.6246 |
| 12:32 ET | 1143 | 0.6234 |
| 12:34 ET | 1663 | 0.6234 |
| 12:36 ET | 4029 | 0.6245 |
| 12:38 ET | 2247 | 0.6246 |
| 12:39 ET | 2085 | 0.6245 |
| 12:41 ET | 2558 | 0.6231 |
| 12:43 ET | 1887 | 0.6246 |
| 12:45 ET | 2832 | 0.624 |
| 12:48 ET | 4280 | 0.6234 |
| 12:50 ET | 2165 | 0.6234 |
| 12:52 ET | 2052 | 0.624 |
| 12:54 ET | 2248 | 0.624 |
| 12:56 ET | 39607 | 0.6234 |
| 12:57 ET | 2291 | 0.623 |
| 12:59 ET | 1484 | 0.6223 |
| 01:01 ET | 3400 | 0.62155 |
| 01:03 ET | 6482 | 0.6223 |
| 01:06 ET | 3664 | 0.62 |
| 01:08 ET | 45186 | 0.621851 |
| 01:10 ET | 27086 | 0.6095 |
| 01:12 ET | 26569 | 0.61 |
| 01:14 ET | 24878 | 0.61 |
| 01:15 ET | 11618 | 0.606 |
| 01:17 ET | 8091 | 0.6013 |
| 01:19 ET | 112973 | 0.5981 |
| 01:21 ET | 13411 | 0.5992 |
| 01:24 ET | 4643 | 0.60265 |
| 01:26 ET | 5661 | 0.60265 |
| 01:28 ET | 5240 | 0.61 |
| 01:30 ET | 1350 | 0.60795 |
| 01:32 ET | 4822 | 0.6088 |
| 01:33 ET | 3246 | 0.60895 |
| 01:35 ET | 2000 | 0.6079 |
| 01:37 ET | 2847 | 0.6091 |
| 01:39 ET | 3507 | 0.6095 |
| 01:42 ET | 4505 | 0.6061 |
| 01:44 ET | 200 | 0.6056 |
| 01:46 ET | 2207 | 0.603 |
| 01:48 ET | 11708 | 0.60375 |
| 01:50 ET | 3502 | 0.60395 |
| 01:51 ET | 4597 | 0.6043 |
| 01:53 ET | 2887 | 0.6042 |
| 01:55 ET | 28626 | 0.61 |
| 01:57 ET | 4332 | 0.61 |
| 02:00 ET | 30237 | 0.6093 |
| 02:02 ET | 9816 | 0.6086 |
| 02:04 ET | 1320 | 0.6081 |
| 02:06 ET | 2100 | 0.6086 |
| 02:08 ET | 656 | 0.6083 |
| 02:09 ET | 4553 | 0.6083 |
| 02:11 ET | 9644 | 0.6107 |
| 02:13 ET | 16765 | 0.6142 |
| 02:15 ET | 10002 | 0.6147 |
| 02:18 ET | 802 | 0.6137 |
| 02:20 ET | 2153 | 0.6137 |
| 02:22 ET | 3466 | 0.6143 |
| 02:24 ET | 2964 | 0.61395 |
| 02:26 ET | 13932 | 0.6143 |
| 02:27 ET | 890 | 0.6135 |
| 02:29 ET | 2772 | 0.6144 |
| 02:31 ET | 2804 | 0.6136 |
| 02:33 ET | 1592 | 0.6142 |
| 02:36 ET | 1919 | 0.61425 |
| 02:38 ET | 1800 | 0.61425 |
| 02:40 ET | 2905 | 0.6144 |
| 02:42 ET | 1826 | 0.6143 |
| 02:44 ET | 794 | 0.6142 |
| 02:45 ET | 2621 | 0.6141 |
| 02:47 ET | 3285 | 0.61425 |
| 02:49 ET | 1160 | 0.6138 |
| 02:51 ET | 1700 | 0.6128 |
| 02:54 ET | 1887 | 0.6106 |
| 02:56 ET | 1339 | 0.6107 |
| 02:58 ET | 3825 | 0.6118 |
| 03:00 ET | 18956 | 0.6118 |
| 03:02 ET | 3235 | 0.6123 |
| 03:03 ET | 2508 | 0.6126 |
| 03:05 ET | 1684 | 0.6136 |
| 03:07 ET | 8481 | 0.6158 |
| 03:09 ET | 2830 | 0.6158 |
| 03:12 ET | 1524 | 0.61575 |
| 03:14 ET | 1593 | 0.6178 |
| 03:16 ET | 1492 | 0.61605 |
| 03:18 ET | 2324 | 0.618 |
| 03:20 ET | 3647 | 0.6159 |
| 03:21 ET | 3355 | 0.6155 |
| 03:23 ET | 2133 | 0.6155 |
| 03:25 ET | 13841 | 0.61465 |
| 03:27 ET | 7901 | 0.6144 |
| 03:30 ET | 5818 | 0.6144 |
| 03:32 ET | 10331 | 0.61555 |
| 03:34 ET | 2298 | 0.6152 |
| 03:36 ET | 3425 | 0.6158 |
| 03:38 ET | 52326 | 0.6202 |
| 03:39 ET | 24246 | 0.61475 |
| 03:41 ET | 37338 | 0.6129 |
| 03:43 ET | 5576 | 0.6114 |
| 03:45 ET | 25489 | 0.6072 |
| 03:48 ET | 46132 | 0.6104 |
| 03:50 ET | 6097 | 0.6104 |
| 03:52 ET | 12285 | 0.6104 |
| 03:54 ET | 24257 | 0.6165 |
| 03:56 ET | 14666 | 0.616 |
| 03:57 ET | 45262 | 0.622 |
| 03:59 ET | 59233 | 0.6 |
Jun 7, 2024
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4), from 5:59PM ET on Friday Jun 07, 2024 by Dow Jones
5:59PM ET on Friday Jun 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kezar Life Sciences Inc | 43.7M | -0.4x | --- |
LAVA Therapeutics NV | 47.3M | -1.7x | --- |
Atara Biotherapeutics Inc | 41.7M | -0.2x | --- |
DURECT Corp | 40.0M | -1.5x | --- |
BioLine RX Ltd | 48.9M | -0.7x | --- |
Evogene Ltd | 32.9M | -1.4x | --- |
Company Information
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer. The Company's lead product candidate, zetomipzomib, is a first-in-class selective immunoproteasome inhibitor that has completed Phase Ia testing in healthy volunteers and a Phase Ib/IIa clinical trial in patients with systemic lupus erythematosus (SLE), with or without lupus nephritis (LN). Its oncology product candidate, KZR-261, is a small molecule agent, targeting the Sec61 translocon and protein secretion pathway, being studied in an open-label Phase I clinical trial designed to evaluate safety and tolerability, pharmacokinetics and pharmacodynamics, as well to explore preliminary anti-tumor activity. This study is being conducted in two parts: dose escalation in patients with locally advanced or metastatic solid malignancies, and dose expansion in patients with selected tumor types.
Contact Information
- Headquarters
- 4000 Shoreline Ct Ste 300SOUTH SAN FRANCISCO, CA, United States 94080-2005
- Phone
- 650-822-5600
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Graham Cooper
- Chief Executive Officer, Director
- Christopher Kirk
- Chief Financial Officer, Secretary
- Marc Belsky
- Chief Business Officer
- Nick Mordwinkin
- Chief Legal Officer
- Mark Schiller
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $43.7M |
|---|---|
Revenue (TTM) | $7.0M |
Shares Outstanding | 72.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.27 |
EPS | $-1.40 |
Book Value | $2.58 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 6.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,591.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
